Deerfield Management Company, L.P. (Series C) Merus N.V. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.37 Billion
Q3 2025

A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Merus N.V. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 3,046,916 shares of MRUS stock, worth $292 Million. This represents 5.34% of its overall portfolio holdings.

Number of Shares

3,046,916

Previous 3,384,628 9.98%

Holding current value

$292 Million

Previous $178 Million 61.13%

% of portfolio

5.34%

Previous 4.09%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$52.33 - $94.15 $17.7 Million - $31.8 Million	-337,712 Reduced 9.98%	3,046,916 $287 Million
Q2 2025 Aug 14, 2025	BUY	$34.89 - $62.42 $7.35 Million - $13.2 Million	210,700 Added 6.64%	3,384,628 $178 Million
Q1 2025 May 15, 2025	BUY	$39.01 - $49.16 $7.85 Million - $9.89 Million	201,141 Added 6.77%	3,173,928 $134 Million
Q4 2024 Feb 14, 2025	SELL	$41.45 - $54.5 $18.1 Million - $23.7 Million	-435,752 Reduced 12.78%	2,972,787 $125 Million
Q3 2024 Nov 14, 2024	BUY	$47.19 - $58.84 $31.1 Million - $38.8 Million	659,138 Added 23.97%	3,408,539 $170 Million
Q2 2024 Aug 14, 2024	BUY	$39.81 - $60.2 $3.98 Million - $6.02 Million	100,000 Added 3.77%	2,749,401 $163 Million
Q1 2024 May 15, 2024	SELL	$28.03 - $51.82 $10.4 Million - $19.2 Million	-370,500 Reduced 12.27%	2,649,401 $119 Million
Q4 2023 Feb 14, 2024	SELL	$20.06 - $28.66 $17.2 Million - $24.6 Million	-857,037 Reduced 22.11%	3,019,901 $83 Million
Q3 2023 Nov 14, 2023	BUY	$20.13 - $27.29 $17 Million - $23.1 Million	845,000 Added 27.87%	3,876,938 $91.4 Million
Q2 2023 Aug 14, 2023	BUY	$18.33 - $27.18 $11.9 Million - $17.7 Million	651,500 Added 27.37%	3,031,938 $79.8 Million
Q4 2022 Feb 14, 2023	SELL	$12.8 - $23.66 $1.81 Million - $3.34 Million	-141,115 Reduced 5.6%	2,380,438 $36.8 Million
Q3 2022 Nov 14, 2022	BUY	$18.64 - $28.93 $9.98 Million - $15.5 Million	535,629 Added 26.97%	2,521,553 $50.5 Million
Q2 2022 Aug 15, 2022	BUY	$13.98 - $29.25 $21.7 Million - $45.3 Million	1,548,924 Added 354.44%	1,985,924 $45 Million
Q4 2021 Feb 14, 2022	BUY	$20.0 - $32.29 $8.74 Million - $14.1 Million	437,000 New	437,000 $13.9 Million

Others Institutions Holding MRUS

# of Institutions

290

Shares Held

64.8M

Call Options Held

1.65M

Put Options Held

758K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $4.4B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account

Deerfield Management Company, L.P. (Series C) Merus N.V. Transaction History